These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 26387984

  • 1. Wogonoside inhibits angiogenesis in breast cancer via suppressing Wnt/β-catenin pathway.
    Huang Y, Zhao K, Hu Y, Zhou Y, Luo X, Li X, Wei L, Li Z, You Q, Guo Q, Lu N.
    Mol Carcinog; 2016 Nov; 55(11):1598-1612. PubMed ID: 26387984
    [Abstract] [Full Text] [Related]

  • 2. Wogonoside Inhibits Prostate Cancer Cell Growth and Metastasis via Regulating Wnt/β-Catenin Pathway and Epithelial-Mesenchymal Transition.
    Wei C, Jing J, Zhang Y, Fang L.
    Pharmacology; 2019 Nov; 104(5-6):312-319. PubMed ID: 31480051
    [Abstract] [Full Text] [Related]

  • 3. Wogonin influences vascular permeability via Wnt/β-catenin pathway.
    Song X, Zhou Y, Zhou M, Huang Y, Li Z, You Q, Lu N, Guo Q.
    Mol Carcinog; 2015 Jul; 54(7):501-12. PubMed ID: 24136474
    [Abstract] [Full Text] [Related]

  • 4. A Systems Pharmacology Approach Uncovers Wogonoside as an Angiogenesis Inhibitor of Triple-Negative Breast Cancer by Targeting Hedgehog Signaling.
    Huang Y, Fang J, Lu W, Wang Z, Wang Q, Hou Y, Jiang X, Reizes O, Lathia J, Nussinov R, Eng C, Cheng F.
    Cell Chem Biol; 2019 Aug 15; 26(8):1143-1158.e6. PubMed ID: 31178408
    [Abstract] [Full Text] [Related]

  • 5. Wogonoside exerts growth-suppressive effects against T acute lymphoblastic leukemia through the STAT3 pathway.
    Xiao R, Gan M, Jiang T.
    Hum Exp Toxicol; 2017 Nov 15; 36(11):1169-1176. PubMed ID: 27941168
    [Abstract] [Full Text] [Related]

  • 6. Wogonoside impedes the progression of acute myeloid leukemia through inhibiting bone marrow angiogenesis.
    Lin B, Zhao K, Yang D, Bai D, Liao Y, Zhou Y, Yu Z, Yu X, Guo Q, Lu N.
    J Cell Physiol; 2019 Feb 15; 234(2):1913-1924. PubMed ID: 30105796
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Wogonoside inhibits tumor growth and metastasis in endometrial cancer via ER stress-Hippo signaling axis.
    Chen S, Wu Z, Ke Y, Shu P, Chen C, Lin R, Shi Q.
    Acta Biochim Biophys Sin (Shanghai); 2019 Nov 18; 51(11):1096-1105. PubMed ID: 31696210
    [Abstract] [Full Text] [Related]

  • 11. LW-213 induces G2/M cell cycle arrest through AKT/GSK3β/β-catenin signaling pathway in human breast cancer cells.
    Zhao L, Miao HC, Li WJ, Sun Y, Huang SL, Li ZY, Guo QL.
    Mol Carcinog; 2016 May 18; 55(5):778-92. PubMed ID: 25945460
    [Abstract] [Full Text] [Related]

  • 12. Ginkgo biloba exocarp extracts inhibits angiogenesis and its effects on Wnt/β-catenin-VEGF signaling pathway in Lewis lung cancer.
    Han D, Cao C, Su Y, Wang J, Sun J, Chen H, Xu A.
    J Ethnopharmacol; 2016 Nov 04; 192():406-412. PubMed ID: 27649680
    [Abstract] [Full Text] [Related]

  • 13. Impact of ER520, a candidate of selective estrogen receptor modulators, on in vitro cell growth, migration, invasion, angiogenesis and in vivo tumor xenograft of human breast cancer cells.
    Wang L, Wang Y, Du H, Jiang Y, Tang Z, Liu H, Xiang H, Xiao H.
    Cancer Chemother Pharmacol; 2015 Dec 04; 76(6):1247-57. PubMed ID: 26464351
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models.
    Wu XY, Xu H, Wu ZF, Chen C, Liu JY, Wu GN, Yao XQ, Liu FK, Li G, Shen L.
    Oncotarget; 2015 Dec 29; 6(42):44563-78. PubMed ID: 26575424
    [Abstract] [Full Text] [Related]

  • 16. MiR-34a Inhibits Breast Cancer Proliferation and Progression by Targeting Wnt1 in Wnt/β-Catenin Signaling Pathway.
    Si W, Li Y, Shao H, Hu R, Wang W, Zhang K, Yang Q.
    Am J Med Sci; 2016 Aug 29; 352(2):191-9. PubMed ID: 27524218
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Scutellaria barbata D. Don inhibits colorectal cancer growth via suppression of Wnt/β-catenin signaling pathway.
    Wei LH, Lin JM, Chu JF, Chen HW, Li QY, Peng J.
    Chin J Integr Med; 2017 Nov 29; 23(11):858-863. PubMed ID: 29080197
    [Abstract] [Full Text] [Related]

  • 19. Kallistatin, a novel anti-angiogenesis agent, inhibits angiogenesis via inhibition of the NF-κB signaling pathway.
    Huang KF, Huang XP, Xiao GQ, Yang HY, Lin JS, Diao Y.
    Biomed Pharmacother; 2014 May 29; 68(4):455-61. PubMed ID: 24721321
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of β-catenin signaling suppresses pancreatic tumor growth by disrupting nuclear β-catenin/TCF-1 complex: critical role of STAT-3.
    Pramanik KC, Fofaria NM, Gupta P, Ranjan A, Kim SH, Srivastava SK.
    Oncotarget; 2015 May 10; 6(13):11561-74. PubMed ID: 25869100
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.